Paris/July 13

From 2008.igem.org

(Difference between revisions)
Line 24: Line 24:
[[Liste of the transformation:]]
[[Liste of the transformation:]]
 +
'''Biobricks 2007'''
'''Biobricks 2007'''
{| border="1"  
{| border="1"  
Line 49: Line 50:
|align="center"|details
|align="center"|details
|align="center"|Strain
|align="center"|Strain
-
|align="center"|Antibiotics
+
|align="center"|Antibio
|align="center"|Plate 2007
|align="center"|Plate 2007
|-
|-
-
|2E_SP 1000
+
|align="center"|2E_SP 1000
-
|B0034
+
|align="center"|B0034
-
|A
+
|align="center"|A
-
|3O P1
+
|align="center"|3O P1
|-
|-
-
|10F_SP 1001
+
|align="center"|10F_SP 1001
-
|R0079  
+
|align="center"|R0079  
-
|A
+
|align="center"|A
-
|19N P1
+
|align="center"|19N P1
|-
|-
|4F_SP 1013
|4F_SP 1013
-
|C0079
+
|align="center"|C0079
-
|K
+
|align="center"|K
-
|7K P2
+
|align="center"|7K P2
|-
|-
-
|6H_SP 1001
+
|align="center"|6H_SP 1001
-
|C0179  
+
|align="center"|C0179  
-
|A
+
|align="center"|A
-
|6H P1
+
|align="center"|6H P1
|-
|-
|6D_SP 1007
|6D_SP 1007
-
|S03879  
+
|align="center"|S03879  
-
|A
+
|align="center"|A
-
| /
+
|align="center"| /
|-
|-
-
|6B_SP 1001
+
|align="center"|6B_SP 1001
-
|S03154  
+
|align="center"|S03154  
-
|A
+
|align="center"|A
-
|24K P1
+
|align="center"|24K P1
|-
|-
-
|10F_SP 1002
+
|align="center"|10F_SP 1002
-
|J23101
+
|align="center"|J23101
-
|A
+
|align="center"|A
-
|21G P3
+
|align="center"|21G P3
|-
|-
-
|11F_SP 1002
+
|align="center"|11F_SP 1002
-
|J23109
+
|align="center"|J23109
-
|A
+
|align="center"|A
-
|23G P3
+
|align="center"|23G P3
|-
|-
-
|4C_SP 1000
+
|align="center"|4C_SP 1000
-
|R0040
+
|align="center"|R0040
-
|A
+
|align="center"|A
-
|7O P1
+
|align="center"|7O P1
|-
|-
-
|2G_SP 1000
+
|align="center"|2G_SP 1000
-
|C0040
+
|align="center"|C0040
-
|A
+
|align="center"|A
-
|5C P1
+
|align="center"|5C P1
|-
|-
-
|1C_SP 1008
+
|align="center"|1C_SP 1008
-
|PSB1A3
+
|align="center"|PSB1A3
-
|A
+
|align="center"|A
-
|23E P1
+
|align="center"|23E P1
|-
|-
|7G_SP 1013
|7G_SP 1013
-
|E1010
+
|align="center"|E1010
-
|K
+
|align="center"|K
-
|15M P2
+
|align="center"|15M P2
|-
|-
|7E_SP 1001
|7E_SP 1001
-
|E0040
+
|align="center"|E0040
-
|A
+
|align="center"|A
-
|5H P1
+
|align="center"|5H P1
|-
|-
|2F_SP 1016
|2F_SP 1016
-
|E0030
+
|align="center"|E0030
-
|K
+
|align="center"|K
-
|7G P1
+
|align="center"|7G P1
|}
|}

Revision as of 18:35, 15 July 2008

 < Yesterday
-
Tomorrow > 

delete


Preparation of Competent Cells

  • Dilution 1/200e (1mL of the O/N culture on 200mL of LB)
  • Culture at 37°C until DO=0,57 (around 3h)
  • Sharing into 4 Falcon tubes of 50mL and cooling at 4°C during 40' in ice
  • Spin during 8', 2000rpm, 4°C
  • Resuspension of the cell's pellet in 20mL of cold CaCl2 (0,1M) during 30' in ice
  • Spin during 8', 2000rpm, 4°C
  • Resuspension of the cell's pellet in 1mL of cold CaCl2 (0,1M)
  • 1h of delay unexpected (problem with DNA lyophilized)
  • Transformation of the Biobricks with the "classical" protocol (--> heat shock at 42°C durin 40")
  • Incubation O/N at 37°C of the transformed bacteria


Remark :

  • Biobricks 2008 : use of the maximum recoverable volume minipreps
  • Biobricks 2007 : use of 3µl of minipreps


Liste of the transformation:

Biobricks 2007

Strain Transformation
MP1 (= J23100) ok
MP2 (= J23107) ok
MP3 (= B0015) ok
MP5 (= JB0030) ok
MP6 (= E0422) ok

Biobricks 2008

details Strain Antibio Plate 2007
2E_SP 1000 B0034 A 3O P1
10F_SP 1001 R0079 A 19N P1
4F_SP 1013 C0079 K 7K P2
6H_SP 1001 C0179 A 6H P1
6D_SP 1007 S03879 A /
6B_SP 1001 S03154 A 24K P1
10F_SP 1002 J23101 A 21G P3
11F_SP 1002 J23109 A 23G P3
4C_SP 1000 R0040 A 7O P1
2G_SP 1000 C0040 A 5C P1
1C_SP 1008 PSB1A3 A 23E P1
7G_SP 1013 E1010 K 15M P2
7E_SP 1001 E0040 A 5H P1
2F_SP 1016 E0030 K 7G P1